These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12154319)

  • 1. Polymorphic forms of cilostazol.
    Whittall LB; Whittle RR; Stowell GW
    Acta Crystallogr C; 2002 Aug; 58(Pt 8):o525-7. PubMed ID: 12154319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two derivatives of 1,5-disubstituted tetrazoles: 1-(4-nitrophenyl)-1H-tetrazol-5-amine and {(E)-[1-(4-ethoxyphenyl)-1H-tetrazol-5-yl]iminomethyl}dimethylamine.
    Lyakhov AS; Vorobiov AN; Ivashkevich LS; Gaponik PN
    Acta Crystallogr C; 2008 Aug; 64(Pt 8):o414-6. PubMed ID: 18682644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human cytochrome p450 enzymes involved in the metabolism of cilostazol.
    Hiratsuka M; Hinai Y; Sasaki T; Konno Y; Imagawa K; Ishikawa M; Mizugaki M
    Drug Metab Dispos; 2007 Oct; 35(10):1730-2. PubMed ID: 17646278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (cilostazol), a phosphodiesterase type 3 inhibitor, reduces infarct size via activation of mitochondrial Ca2+-activated K+ channels in rabbit hearts.
    Fukasawa M; Nishida H; Sato T; Miyazaki M; Nakaya H
    J Pharmacol Exp Ther; 2008 Jul; 326(1):100-4. PubMed ID: 18381926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrared spectra and X-ray structure of (tetrazol-5-yl)acetic acid.
    Pagacz-Kostrzewa M; Jesariew D; Podruczna M; Wierzejewska M
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 May; 108():229-35. PubMed ID: 23474482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of cilostazol.
    Schrör K
    Diabetes Obes Metab; 2002 Mar; 4 Suppl 2():S14-9. PubMed ID: 12180353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-(5-Nitropyridin-2-yldithio)-1-phenyl-1H-tetrazole.
    Brito I; Mundaca A; Cárdenas A; López-Rodríguez M
    Acta Crystallogr C; 2007 Oct; 63(Pt 10):o606-8. PubMed ID: 17917235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cilostazol on platelet aggregation and experimental thrombosis.
    Kimura Y; Tani T; Kanbe T; Watanabe K
    Arzneimittelforschung; 1985; 35(7A):1144-9. PubMed ID: 4074426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic forms of lupane triterpenoid betulonic aldehyde (betulonal).
    Chrobak E; Michalik E; Kusz J; Nowak M; Boryczka S
    Acta Crystallogr C Struct Chem; 2014 Sep; 70(Pt 9):847-51. PubMed ID: 25186355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tetrazol-5-yl analogue of glycine, 5-ammoniomethyl-1H-tetrazolide, and its copper(II) complex.
    Lyakhov AS; Voitekhovich SV; Ivashkevich LS; Gaponik PN
    Acta Crystallogr C; 2010 Feb; 66(Pt 2):m22-5. PubMed ID: 20124673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two polymorphic forms of N-(4-chlorophenyl)-5-[(4-chlorophenyl)aminomethyl]-6-methyl-2-phenylpyrimidin-4-amine.
    Cieplik J; Pluta J; Bryndal I; Lis T
    Acta Crystallogr C; 2006 May; 62(Pt 5):o259-61. PubMed ID: 16679597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cilostazol with warfarin as antithrombotic therapy after femoro-popliteal bypass surgery using an ePTFE graft.
    Ohtake H; Urayama H; Kimura K; Yokoi K; Tsunezuka Y; Kawakami T; Kawasuji M; Watanabe Y
    Minerva Cardioangiol; 1997 Nov; 45(11):527-30. PubMed ID: 9549283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the structural motifs and packing arrangements of six novel derivatives and one polymorph of 2-(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine.
    Tawfiq KM; Miller GJ; Al-Jeboori MJ; Fennell PS; Coles SJ; Tizzard GJ; Wilson C; Potgieter H
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2014 Apr; 70(Pt 2):379-89. PubMed ID: 24675607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation and structural elucidation of a new impurity in bulk drug of cilostazol by LC/MS/MS, FT-IR and NMR.
    Hu Z; Gao S; Gao J
    J Pharm Biomed Anal; 2017 Oct; 145():16-23. PubMed ID: 28646658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An X-ray powder diffraction study of cis-dichloridobis(2-methyl-2H-tetrazol-5-amine-κN(4))platinum(II), a tetrazole-containing analogue of cisplatin.
    Ivashkevich LS; Serebryanskaya TV; Lyakhov AS; Gaponik PN
    Acta Crystallogr C; 2011 Jun; 67(Pt 6):m195-8. PubMed ID: 21633152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.
    Shintani S; Toba Y; Suzuki S; Ninomiya S; Umezato M; Hiyama T
    Arzneimittelforschung; 1985; 35(7A):1157-62. PubMed ID: 4074429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat.
    Wang C; Wang C; Liu Q; Meng Q; Cang J; Sun H; Peng J; Ma X; Huo X; Liu K
    Drug Metab Dispos; 2014 Jun; 42(6):996-1007. PubMed ID: 24692216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Van der Waals versus hydrogen-bonding forces in a crystalline analog of cellotetraose: cyclohexyl 4'-O-cyclohexyl beta-D-cellobioside cyclohexane solvate.
    Yoneda Y; Mereiter K; Jaeger C; Brecker L; Kosma P; Rosenau T; French A
    J Am Chem Soc; 2008 Dec; 130(49):16678-90. PubMed ID: 19554694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bitter sweeteners: tetrazole derivatives of arylsulfonylalcanoids--synthesis, structure and comparative study.
    Kalinowska-Tłuścik J; Jarzembek K; Sliwiński J; Oleksyn BJ; Kozik V; Polański J
    Acta Crystallogr B; 2008 Dec; 64(Pt 6):760-70. PubMed ID: 19029705
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.